Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines

Published:2010-02 Issue:2 Volume:21 Page:255-262
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kataoka Y.,Mukohara T.,Shimada H.,Saijo N.,Hirai M.,Minami H.

Funder

Ministry of Education, Culture, Sports, Science and Technology of Japan

AstraZeneca Research Grant 2007

Kobe University Medical School Research Grant for Young Scientists

Ministry of Health, Labor and Welfare of Japan

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/2/255/924823/mdp304.pdf

Reference36 articles.

1. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics;McPherson;BMJ,2000

2. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

3. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced anti-tumor effects by combination of tucatinib and radiation in HER2-overexpressing human cancer cell lines;Cancer Cell International;2024-08-06

2. Personalized treatment using predictive biomarkers in solid organ malignancies: A review;Tumori Journal;2024-08-02

3. HER2/PI3K/AKT pathway in HER2-positive breast cancer: A review;Medicine;2024-06-14

4. The role of SIK3 in HER2+ gastric cancer cells;BIOS;2024-05-29

5. Trastuzumab Response in Iraqi Women with Her2 Positive Breast Cancer: The Role of PIK3CA Oncogene Mutations at E542k and E545k;MED BALEAR;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3